Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existing healthcare infrastructure. As the UAE is aiming to introduce comprehensive health insurance throughout the country, allowing businesses to...
Jul 2014 $ 1295
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused on improving the domestic pharmaceutic...
Jul 2014 $ 1295
South Africa Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market - boasting the largest medicines market on the continent and poised for high single-digit growth over the next deca...
Jul 2014 $ 1295
Qatar Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Medicine prices are expected to decline shortly in Qatar amid the 'imminent' unification of medicine importation channels and the adoption of a new medicine pricing mechanism by the member countries of the Gulf Co-operation Coun...
Jul 2014 $ 1295
Portugal Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Faster-than-expected economic growth last quarter has led us to revise our healthcare and pharmaceutical forecasts slightly upwards. As forecast previously, BMI expects Portugal's healthcare market to return to growth in 2015, w...
Jul 2014 $ 1295
Malaysia Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality and access to healthcare, as the government plans to expand and upgrade its hospital network. However, we have downgraded Malaysia's pharmace...
Jul 2014 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014, and the prospects for consumption remain bright. While price harmonisation across the GCC is likely to have a significant impact on mar...
Jul 2014 $ 1295
Iraq Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Thanks to the government's expansionary fiscal policy, spending on education, health and public services will increase. The Iraqi government has reportedly pledged to invest USD12bn into healthcare expansions in 2014, and the Mi...
Jul 2014 $ 1295
Denmark Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Like many other Western European countries, Denmark's expanding elderly population will ensure that demand for quality healthcare remains high and will be a key driving factor for its wellestablished, albeit relatively small, ph...
Jul 2014 $ 1295
Czech Republic Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales data from the first quarter. Price declines throughout Europe and restructuring of the healthcare system will continue to impact demand wit...
Jul 2014 $ 1295
Spain Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: The weakened Spanish economy and the government's ongoing multi-faceted strategy to contain expenditure on prescription medicines by targeting patients, companies and the overall healthcare sector present challenges to drugmaker...
Jul 2014 $ 1295
Slovakia Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: The Slovakian government is planning to allocate EUR278mn (USD386.7mn) in EU funding to develop healthcare and medical infrastructure in Slovakia over the 2014-2020 period, reports news agency TASR. The government added that aft...
Jul 2014 $ 1295
Serbia Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
The new Serbian government is actively trying to stabilise the country's fiscal position through cutting spending, encouraging outside investment and demand pickup for Serbian exports in order to reduce its debt burden. However, pharmaceu...
Jul 2014 $ 1295
Moldova Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: BMI has upgraded its forecast for Moldova's pharmaceutical and healthcare market for 2014 due to improved economic conditions. Moldova is likely to sign the Association Agreement with the EU in June 2014, which would strength...
Jul 2014 $ 1295
Lithuania Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growth rate (CAGR) of 3.8%, rising to a value of LTL2.11bn (USD732mn) in 2018. The upcoming switch to the euro promises to boost purchasing po...
Jul 2014 $ 1295
Greece Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: The Greek pharmaceutical and healthcare sector will continue contract over the medium-tolong term. Although Greece's financial outlook has stabilised and debts are being paid down, the government will continue to target the p...
Jul 2014 $ 1295
Ghana Pharmaceuticals and Healthcare Report Q3 2014
By Business Monitor International
BMI View: Continuing depreciation in the Ghanaian currency has led us to revise our headline forecasts in USD for the pharmaceutical sector downwards. In the long-term however we remain positive for the sector with the government's foc...
Jul 2014 $ 1295
Exenatide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Denosumab - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Mipomersen - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Ticagrelor - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Paliperidone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Fosaprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Enzalutamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Aprepitant - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
By Ark Patent Intelligence
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot save...
Jul 2014 $ 600
Live Chat
Live Chat by Comm100